Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Marianna Beggio"'
Autor:
Mariele Gatto, Roberto Luisetto, Anna Ghirardello, Laura Cavicchioli, Gaia Codolo, Alessandra Biasiolo, Giuseppe Maggioni, Francesca Saccon, Marianna Beggio, Andrea Cappon, Roberta Venturini, Patrizia Pontisso, Andrea Doria
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Objective: To explore the effects of SERPINB3 administration in murine lupus models with a focus on lupus-like nephritis.Methods: 40 NZB/W F1 mice were subdivided into 4 groups and intraperitoneally injected with recombinant SERPINB3 (7.5 μg/0.1 mL
Externí odkaz:
https://doaj.org/article/60ac7311ad9141e68f6b691a5654d7ee
Autor:
M. Schiesaro, M. Caputo, E. Pigatto, Paolo Sfriso, Marianna Beggio, Paola Galozzi, Franco Cozzi
Publikováno v:
Annals of the Rheumatic Diseases. 80:392.1-392
Background:Gastrointestinal (GI) involvement is very common in patients with Systemic Sclerosis (SSc). The pathophysiology of GI manifestations has not yet been defined. Cell-mediated immunological reactions appear to lead to endothelial damage resul
Autor:
Anna Ghirardello, Marianna Beggio, Franco Schiavon, Mara Felicetti, Roberto Padoan, Andrea Doria
Publikováno v:
Rheumatology. 58
Autor:
Roberto Luisetto, Patrizia Pontisso, Giuseppe Maggioni, Francesca Saccon, Marianna Beggio, Gaia Codolo, Laura Cavicchioli, Mariele Gatto, Anna Ghirardello, Andrea Doria
Publikováno v:
S7a – New therapeutic candidates.
Background Abnormal apoptosis and clearance of cellular debris concur to development of systemic lupus erythematosus (SLE). SERPINS (serin-protease inhibitors) are ancient molecules regulating immune homeostasis. SERPINB3 modulates apoptosis and is h
Autor:
Anna Ghirardello, Patrizia Pontisso, Giuseppe Maggioni, Alessandra Biasiolo, Roberto Luisetto, Andrea Cappon, Francesca Saccon, Roberta Venturini, Marianna Beggio, Gaia Codolo, Laura Cavicchioli, Mariele Gatto, Andrea Doria
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Objective: To explore the effects of SERPINB3 administration in murine lupus models with a focus on lupus-like nephritis. Methods: 40 NZB/W F1 mice were subdivided into 4 groups and intraperitoneally injected with recombinant SERPINB3 (7.5 μg/0.1 mL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed79f557208faae8ee9f43119bd077fc
http://hdl.handle.net/11577/3280977
http://hdl.handle.net/11577/3280977
Autor:
Francesca Oliviero, F Leite de Oliveira, Paolo Sfriso, Roberto Luisetto, Franco Cozzi, Elisabetta Zanatta, E. Pigatto, Leonardo Punzi, A Peruffo, Marianna Beggio, Anna Scanu
Publikováno v:
Abstracts Accepted for Publication.
Background Scleroderma (SSc) is a connective tissue disease characterized by immunomediated inflammation and fibrosis. The presence of autoantibodies against chromosome associate proteins,such as anti-centromere proteins and anti-topoisomerase I, was
Autor:
Anna, Ghirardello, Silvano, Bettio, Nicola, Bassi, Mariele, Gatto, Marianna, Beggio, Ingrid, Lundberg, Gaetano, Vattemi, Luca, Iaccarino, Leonardo, Punzi, Andrea, Doria
Publikováno v:
Clinical and experimental rheumatology. 35(1)
Autor:
Anna Ghirardello, Elisabetta Borella, Franco Franceschini, Andrea Doria, Micaela Fredi, Marianna Beggio
Publikováno v:
Auto-Immunity Highlights
Autoantibodies are powerful diagnostic tools in idiopathic inflammatory myopathies, especially for confirming the diagnosis and contributing to the definition of disease subsets. They are present in over 80 % of patients with immuno-mediated myositis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77b929039baf468492c2ceb641ed129e
http://hdl.handle.net/11577/3194955
http://hdl.handle.net/11577/3194955
Autor:
Marianna Beggio, D. Astorri, Leonardo Punzi, A. Ghiraldello, Andrea Doria, L. Friso, Bernd Raffeiner, L. Bernardi, Roberto Padoan, Costantino Botsios, Francesca Ometto
Publikováno v:
Annals of the Rheumatic Diseases. 75:494.1-494
Objectives To investigate etanercept (ETN) serum levels and anti-etanercept antibodies (AEA) and evaluate whether ETN levels are associated with SDAI remission in rheumatoid arthritis patients in DAS28 remission treated with full-dose (25 mg twice we